Clinical Trial Update: Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy

View source ↗

Summary

A long-term follow-up study of the AAVAnc80-hOTOF gene therapy for otoferlin-related hearing loss is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otoferlin-related Hearing Loss

Drugs mentioned

• AAVAnc80-hOTOF gene therapy (AAVAnc80-hOTOF)

Snippet

Sponsor: Akouos, Inc. | Conditions: Otoferlin Gene-mediated Hearing Loss | Status: ENROLLING_BY_INVITATION